• $291,789.00
    Market Cap
  • 0.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
01/31/2023
01/31/2022
01/31/2021
Income Statement
Total Operating Revenue
67,996
-26.10%
92,014
+849.87%
9,687
N/A
Cost of Revenue
32,690
-46.28%
60,853
+41.70%
42,944
N/A
Gross Profit
35,306
+13.30%
31,161
+193.70%
-33,257
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
78,906
+1.44%
77,785
+153.65%
30,666
N/A
Total Operating Expenses
32,690
-46.28%
60,853
+41.70%
42,944
N/A
Operating Profit
-297,675
-48.99%
-583,582
+21.92%
-478,665
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-62,063
+2.40%
-60,606
-50.18%
-121,648
N/A
Interest Income and Expense and Net
-62,063
+2.40%
-60,606
-50.18%
-121,648
N/A
Total Nonoperating Income and Expense
-260,219
+427.36%
-49,344
-18.07%
-60,227
N/A
Income before Taxes
-557,894
-24.83%
-742,188
+27.81%
-580,692
N/A
Income Taxes
3,523
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-561,417
-11.30%
-632,926
+17.45%
-538,892
N/A
Net Income from Continuing Operations Applicable to Common
-576,862
-22.28%
-742,188
+27.81%
-580,692
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
0.00
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
0.00
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
1.2B
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
1.2B
N/A
Balance Sheet
Cash and Cash Equivalents
1,969
+86.46%
1,056
-95.47%
23,308
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1,969
+86.46%
1,056
-95.47%
23,308
N/A
Total Current Assets
25,815
+868.30%
2,666
-89.31%
24,943
N/A
Accumulated Depreciation
187,357
+72.76%
108,451
+253.65%
30,666
N/A
Property and Plant and Equipment and Net
49,360
-61.52%
128,266
-22.65%
165,824
N/A
Total Long-Term Assets
49,360
-61.52%
128,266
-22.65%
165,824
N/A
Total Assets
75,175
-42.58%
130,932
-31.37%
190,767
N/A
Income Taxes Payable
N/A
N/A
37,135
0.00%
37,135
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
759,639
-34.17%
1.2M
+15.17%
1.0M
N/A
Total Long-Term Debt
54,156
-77.41%
239,711
0.00%
239,711
N/A
Total Long-Term Liabilities
54,156
N/A
N/A
N/A
N/A
N/A
Total Liabilities
813,795
-29.48%
1.2M
+15.17%
1.0M
N/A
Retained Earnings
-11.5M
+5.30%
-10.9M
+7.32%
-10.1M
N/A
Total Stockholders Equity
-773,820
-39.21%
-1.3M
+31.58%
-967,476
N/A
Total Shares Outstanding
2.7B
+53.95%
1.8B
+19.38%
1.5B
N/A
Cash Flow
Cash from Operating Activities
-153,243
-62.22%
-405,615
-1.64%
-412,378
N/A
Capital Expenditures
N/A
N/A
40,227
-79.53%
196,490
N/A
Cash from Investing Activities
N/A
N/A
-40,227
-79.53%
-196,490
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
154,156
-63.61%
423,590
-6.90%
455,000
N/A
Financials Ratio
Gross Margin
51.92%
+53.32%
33.87%
+109.86%
-343.32%
N/A
Operating Margin
-437.78%
-30.97%
-634.23%
-87.16%
-4,941.31%
N/A
Return on Assets
-544.78%
+38.45%
-393.49%
+36.22%
-288.87%
N/A
Return on Equity
54.86%
-2.91%
56.50%
-4.75%
59.32%
N/A
Revenue Growth
-26.10%
-103.07%
849.87%
+1,550.95%
51.48%
N/A
Current Ratio
0.03
+1,378.26%
0.002
-90.76%
0.02
N/A
Cash Ratio
0.003
+188.89%
0.0009
-96.14%
0.02
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow